Compared with other CVOTs involving GLP-1RA, participants in the AMPLITUDE-O trial had the longest duration of diabetes (15 years), lowest mean eGFR (72 ml/min/1.73 m 2 ) with a higher percentage (32%) of people with renal disease (eGFR 2560 mL/min), highest glycosilated hemoglobin (8.9%), and highest percentage of insulin use (62%) or sodiumglucose transporter-2 inhibitors (SGLT-2i) (15%) at baseline, thus identifying a more fragile population
Patients commonly report improved tolerance once stable dosing is achieved
Knowing which foods to avoid is important
Our healthcare provider in Covington will track your progress monthly, helping fine-tune your medication for optimal results
However, Contrave is FDA-approved for weight loss which may make it easier to qualify if you do not have depression or are not currently smoking cigarettes
In December, the FDA took tirzapetide off its shortages list